Zhenjiang Zhao - Publications

Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events.

Journal: Oxidative medicine and cellular longevity

Published: January 21, 2020

Curcumin Modulates Hepatocellular Carcinoma by Reducing UNC119 Expression.

Journal: Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer

Published: November 04, 2019

Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma.

Journal: Molecular carcinogenesis

Published: November 20, 2018

Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways.

Journal: Inflammopharmacology

Published: October 01, 2018

ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 23, 2018

Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway.

Journal: International journal of molecular medicine

Published: May 09, 2018

RSK2 is required for TRAF6 phosphorylation-mediated colon inflammation.

Journal: Oncogene

Published: May 10, 2017

APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model.

Journal: Oncotarget

Published: November 17, 2016